Proxygen GmbH
Back to list
Facts
- Founded
- 2020
- Staff
- 9
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Focus
- human health
Profile
Proxygen harnesses the cellular protein quality control system to develop therapies against cancer and other life-threatening diseases. We are focused on particular small molecules called “molecular glue degraders” which mediate recruitment of a disease-causing protein to a ubiquitin ligase where it is ubiquitinated and directed to the proteasome for degradation. Hence, instead of merely blocking the function of harmful proteins, molecular glue degraders enable their complete and selective elimi
Similar companies in RDM biotech/pharma
EveliQure Biotechnologies GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- human health
Janssen-Cilag Pharma GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Cluster
- LISAvienna
- Focus
- human health
DirectSens GmbH
- Organization type
- RDM biotech/pharma
- Region
- Lower Austria
- Cluster
- ecoplus
- Focus
- non-specific applications
Algonist Biotechnologies GmbH
- Organization type
- RDM biotech/pharma
- Region
- Vienna
- Focus
- human health